Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage

Biochemical and Biophysical Research Communications

Volumn 318, Issue 4, 2004, Pages 856-861

  Adachi, Noritaka ^a   Iiizumi, Susumu ^a   So, Sairei ^a   Koyama, Hideki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; KU ANTIGEN; MUTANT PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; HUMAN; HUMAN CELL; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CHICKENS; DNA DAMAGE; DNA LIGASES; DNA REPAIR; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; PHENOTYPE; PIPERAZINES; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC;

GALLUS GALLUS; VERTEBRATA;

EID: 2442504893     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.099     Document Type: Article

References (33)

1. Lieber M.R., Ma Y., Pannicke U., Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 4:2003;712-720
2. Lieber M.R. The biochemistry and biological significance of nonhomologous DNA end joining: an essential repair process in multicellular eukaryotes. Genes Cells. 4:1999;77-85
3. Jackson S.P. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 23:2002;687-696
4. Grawunder U., Zimmer D., Fugmann S., Schwarz K., Lieber M.R. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol. Cell. 2:1998;477-484
5. Adachi N., Ishino T., Ishii Y., Takeda S., Koyama H. DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: implications for DNA double-strand break repair. Proc. Natl. Acad. Sci. USA. 98:2001;12109-12113
6. Kulesza P., Lieber M.R. DNA-PK is essential only for coding joint formation in V(D)J recombination. Nucleic Acids Res. 26:1998;3944-3948
7. Gao Y., Chaudhuri J., Zhu C., Davidson L., Weaver D.T., Alt F.W. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity. 9:1998;367-376
8. Rooney S., Sekiguchi J., Zhu C., Cheng H.L., Manis J., Whitlow S., DeVido J., Foy D., Chaudhuri J., Lombard D., Alt F.W. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol. Cell. 10:2002;1379-1390
9. Fukushima T., Takata M., Morrison C., Araki R., Fujimori A., Abe M., Tatsumi K., Jasin M., Dhar P.K., Sonoda E., Chiba T., Takeda S. Genetic analysis of the DNA-dependent protein kinase reveals an inhibitory role of Ku in late S-G2 phase DNA double-strand break repair. J. Biol. Chem. 276:2001;44413-44418
10. Wang J.C. DNA topoisomerases. Annu. Rev. Biochem. 65:1996;635-692
11. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3:2002;430-440
12. Adachi N., Suzuki H., Iiizumi S., Koyama H. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage. J. Biol. Chem. 278:2003;35897-35902
13. Caldecott K., Banks G., Jeggo P. The induction and reversal of topoisomerase II cleavable complexes formed by nuclear extract from the CHO DNA repair mutant, xrs1. Mutat. Res. 293:1993;259-267
14. Caldecott K., Banks G., Jeggo P. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II. Cancer Res. 50:1990;5778-5783
15. Hong G., Kreuzer K.N. Endonuclease cleavage of blocked replication forks: an indirect pathway of DNA damage from antitumor drug-topoisomerase complexes. Proc. Natl. Acad. Sci. USA. 100:2003;5046-5051
16. Liu L.F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:1989;351-375
17. Nitiss J.L., Wang J.C. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol. Pharmacol. 50:1996;1095-1102
18. Vance J.R., Wilson T.E. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc. Natl. Acad. Sci. USA. 99:2002;13669-13674
19. Sabourin M., Nitiss J.L., Nitiss K.C., Tatebayashi K., Ikeda H., Osheroff N. Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks. Nucleic Acids Res. 31:2003;4373-4384
20. Filippini G., Griffin S., Uhr M., Eppenberger H., Bonilla J., Cavalli F., Soldati G. A novel flow cytometric method for the quantification of p53 gene expression. Cytometry. 31:1998;180-186
21. Buerstedde J.M., Takeda S. Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell. 67:1991;179-188
22. Takata M., Sasaki M.S., Sonoda E., Morrison C., Hashimoto M., Utsumi H., Yamaguchi-Iwai Y., Shinohara A., Takeda S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17:1998;5497-5508
23. Jin S., Inoue S., Weaver D.T. Differential etoposide sensitivity of cells deficient in the Ku and DNA-PKcs components of the DNA-dependent protein kinase. Carcinogenesis. 19:1998;965-971
24. Ma Y., Pannicke U., Schwarz K., Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell. 108:2002;781-794
25. Nicolas N., Moshous D., Cavazzana-Calvo M., Papadopoulo D., de Chasseval R., Le Deist F., Fischer A., de Villartay J.P. A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangements defines a new DNA recombination/repair deficiency. J. Exp. Med. 188:1998;627-634
26. Clatworthy A.E., Valencia M.A., Haber J.E., Oettinger M.A. V(D)J recombination and RAG-mediated transposition in yeast. Mol. Cell. 12:2003;489-499
27. Tsai C.L., Drejer A.H., Schatz D.G. Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination. Genes Dev. 16:2002;1934-1949
28. Roca J., Ishida R., Berger J.M., Andoh T., Wang J.C. Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc. Natl. Acad. Sci. USA. 91:1994;1781-1785
29. Morris S.K., Baird C.L., Lindsley J.E. Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193. J. Biol. Chem. 275:2000;2613-2618
30. Mao Y., Desai S.D., Ting C.Y., Hwang J., Liu L.F. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. J. Biol. Chem. 276:2001;40652-40658
31. Xiao H., Mao Y., Desai S.D., Zhou N., Ting C.Y., Hwang J., Liu L.F. The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway. Proc. Natl. Acad. Sci. USA. 100:2003;3239-3244
32. Hajji N., Pastor N., Mateos S., Dominguez I., Cortes F. DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193. Mutat. Res. 530:2003;35-46
33. Karanjawala Z.E., Adachi N., Irvine R.A., Oh E.K., Shibata D., Schwarz K., Hsieh C.L., Lieber M.R. The embryonic lethality in DNA ligase IV-deficient mice is rescued by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ mutants. DNA Repair. 1:2002;1017-1026